tirzepatide and blood pressure Systolic reduction with in patients with type 2 diabetes: insights from SURPASS clinical program | Cardiovascular Diabetology Tirzepatide Blood Pressure Reduction: Clinical

This investment is likely to improve access to medications like Semaglutide, as healthcare providers are better equipped to offer comprehensive treatment options

A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an eye stroke

Hyperlysinemia type II is an autosomal recessive disorder exhibiting variable phenotypes that may include intellectual disability, seizures, and delayed speech and language development

Here we report a simple, robust, cost effective and rapid screen capable of assessing multiple hPSC lines for their EP purely by morphology

Target: 1.2 to 1.6 g per kilogram of body weight a day, at least 60 g

They typically subsided, but did cause about 5% of trial participants to stop taking the drug